FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584535722> ?p ?o ?g. }

• W2584535722 endingPage "16593" @default.
• W2584535722 startingPage "16581" @default.
• W2584535722 abstract "// Yutaka Hashimoto 1, * , Marisa Shiina 1, * , Taku Kato 1 , Soichiro Yamamura 1 , Yuichiro Tanaka 1 , Shahana Majid 1 , Sharanjot Saini 1 , Varahram Shahryari 1 , Priyanka Kulkarni 1 , Pritha Dasgupta 1 , Yozo Mitsui 1 , Mitsuho Sumida 1 , Guoren Deng 1 , Laura Tabatabai 2 , Deepak Kumar 3 , Rajvir Dahiya 1 1 Department of Urology, VA Medical Center and UCSF, San Francisco, CA 94121, USA 2 Department of Pathology, Veterans Affairs Medical Center and University of California at San Francisco, San Francisco, CA 94121, USA 3 Julius L. Chambers Biomedical/Biotechnology Research Institute (BBRI), Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC 27707, USA * These authors contributed equally to this work Correspondence to: Rajvir Dahiya, email: Rdahiya@ucsf.edu Keywords: race related prostate cancer, miRNA, pathway modulation, DNA methylation Received: December 01, 2016      Accepted: January 24, 2017      Published: February 02, 2017 ABSTRACT The incidence of prostate cancer (PCa) among African-Americans (AfA) is significantly higher than Caucasian-Americans (CaA) but the genetic basis for this disparity is not known. To address this problem, we analyzed miRNA expression in AfA ( n = 81) and CaA ( n = 51) PCa patients. Here, we found that miR-24 is differentially expressed in AfA and CaA PCa patients and attempt to clarify its role in AfA patients. Also, the public sequencing data of the miR-24 promoter confirmed that it was highly methylated and down-regulated in PCa patients. Utilizing a VAMCSF and NDRI patient cohorts, we discovered that miR-24 expression was linked to a racial difference between AfA/CaA PCa patients. Interestingly, miR-24 was restored after treatment of PCa cells with 5Aza-CdR in an AfA cell line (MDA-PCa-2b), while restoration of miR-24 was not observed in CaA cells, DU-145. Ectopic expression of miR-24 showed decreased growth and induced apoptosis, though the effect was less in the CaA cell line compared to the AfA cell line. Finally, we found unique changes in biological pathways and processes associated with miR-24 transfected AfA cells by quantitative PCR-based gene expression array. Evaluation of the altered pathways showed that AR, IGF1, IGFBP5 and ETV1 were markedly decreased in the AfA derived cell line compared with CaA cells, and there was a reciprocal regulatory relationship of miR-24/target expression in prostate cancer patients. These results demonstrate that miR-24 may be a central regulator of key events that contribute to race-related tumorigenesis and has potential to be a therapeutic agent for PCa treatment." @default.
• W2584535722 created "2017-02-10" @default.
• W2584535722 creator A5000406250 @default.
• W2584535722 creator A5003443702 @default.
• W2584535722 creator A5003506806 @default.
• W2584535722 creator A5005265859 @default.
• W2584535722 creator A5010322106 @default.
• W2584535722 creator A5012638832 @default.
• W2584535722 creator A5017503324 @default.
• W2584535722 creator A5027943200 @default.
• W2584535722 creator A5033582740 @default.
• W2584535722 creator A5035556760 @default.
• W2584535722 creator A5047605026 @default.
• W2584535722 creator A5061286794 @default.
• W2584535722 creator A5071471877 @default.
• W2584535722 creator A5085150253 @default.
• W2584535722 creator A5089838443 @default.
• W2584535722 creator A5091043128 @default.
• W2584535722 date "2017-02-02" @default.
• W2584535722 modified "2023-09-25" @default.
• W2584535722 title "The role of miR-24 as a race related genetic factor in prostate cancer" @default.
• W2584535722 cites W1422310337 @default.
• W2584535722 cites W1818280568 @default.
• W2584535722 cites W1963691340 @default.
• W2584535722 cites W1968384034 @default.
• W2584535722 cites W1987903396 @default.
• W2584535722 cites W1988258975 @default.
• W2584535722 cites W1989683537 @default.
• W2584535722 cites W1995404520 @default.
• W2584535722 cites W2018502442 @default.
• W2584535722 cites W2026570544 @default.
• W2584535722 cites W2027003678 @default.
• W2584535722 cites W2038164645 @default.
• W2584535722 cites W2064322303 @default.
• W2584535722 cites W2065218625 @default.
• W2584535722 cites W2067869708 @default.
• W2584535722 cites W2071463092 @default.
• W2584535722 cites W2077356336 @default.
• W2584535722 cites W2091508328 @default.
• W2584535722 cites W2093221289 @default.
• W2584535722 cites W2098248674 @default.
• W2584535722 cites W2115874527 @default.
• W2584535722 cites W2118699447 @default.
• W2584535722 cites W2120208667 @default.
• W2584535722 cites W2134548024 @default.
• W2584535722 cites W2136159134 @default.
• W2584535722 cites W2141224543 @default.
• W2584535722 cites W2145231286 @default.
• W2584535722 cites W2152445275 @default.
• W2584535722 cites W2154403396 @default.
• W2584535722 cites W2164716330 @default.
• W2584535722 cites W2164895949 @default.
• W2584535722 cites W2252879097 @default.
• W2584535722 cites W2259625163 @default.
• W2584535722 cites W2278355657 @default.
• W2584535722 cites W2327146806 @default.
• W2584535722 cites W2335686898 @default.
• W2584535722 doi "https://doi.org/10.18632/oncotarget.15016" @default.
• W2584535722 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5369986" @default.
• W2584535722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28157714" @default.
• W2584535722 hasPublicationYear "2017" @default.
• W2584535722 type Work @default.
• W2584535722 sameAs 2584535722 @default.
• W2584535722 citedByCount "21" @default.
• W2584535722 countsByYear W25845357222017 @default.
• W2584535722 countsByYear W25845357222018 @default.
• W2584535722 countsByYear W25845357222019 @default.
• W2584535722 countsByYear W25845357222020 @default.
• W2584535722 countsByYear W25845357222021 @default.
• W2584535722 countsByYear W25845357222022 @default.
• W2584535722 countsByYear W25845357222023 @default.
• W2584535722 crossrefType "journal-article" @default.
• W2584535722 hasAuthorship W2584535722A5000406250 @default.
• W2584535722 hasAuthorship W2584535722A5003443702 @default.
• W2584535722 hasAuthorship W2584535722A5003506806 @default.
• W2584535722 hasAuthorship W2584535722A5005265859 @default.
• W2584535722 hasAuthorship W2584535722A5010322106 @default.
• W2584535722 hasAuthorship W2584535722A5012638832 @default.
• W2584535722 hasAuthorship W2584535722A5017503324 @default.
• W2584535722 hasAuthorship W2584535722A5027943200 @default.
• W2584535722 hasAuthorship W2584535722A5033582740 @default.
• W2584535722 hasAuthorship W2584535722A5035556760 @default.
• W2584535722 hasAuthorship W2584535722A5047605026 @default.
• W2584535722 hasAuthorship W2584535722A5061286794 @default.
• W2584535722 hasAuthorship W2584535722A5071471877 @default.
• W2584535722 hasAuthorship W2584535722A5085150253 @default.
• W2584535722 hasAuthorship W2584535722A5089838443 @default.
• W2584535722 hasAuthorship W2584535722A5091043128 @default.
• W2584535722 hasBestOaLocation W25845357221 @default.
• W2584535722 hasConcept C120665830 @default.
• W2584535722 hasConcept C121332964 @default.
• W2584535722 hasConcept C121608353 @default.
• W2584535722 hasConcept C126322002 @default.
• W2584535722 hasConcept C143998085 @default.
• W2584535722 hasConcept C2780192828 @default.
• W2584535722 hasConcept C512399662 @default.
• W2584535722 hasConcept C61511704 @default.
• W2584535722 hasConcept C71924100 @default.

• next